These recommendations are based on results that showed that GLP-1RA compared with insulin therapy (basal, premixed, or intensified basal-bolus regimens) have similar or even better efficacy in HbA1c reduction and a lower hypoglycemia risk, promotes weight loss instead of weight gain, and reduces the burden of drug administration frequency and self-monitoring of blood glucose [1, 2]
It says patients with higher baseline insulin resistance sometimes see more pronounced metabolic benefits, while those already in better metabolic control may experience more modest weight changes
Small, consistent changes beat drastic swings for both weight and gallbladder health
Consistent quality: ISO-aligned manufacturing and handling keep product integrity reliable batch to batch
Side effects are common and of concern, though
Allergic reactions: Though extremely rare, swelling, difficulty breathing, or a rash may indicate an allergic response that requires immediate medical attention